Coronavirus: Abbott’s 15-minute COVID-19 Self-Test for Only $5
On August 26, the US Food and Drug Administration (FDA) issued an emergency use authorization to Abbott’s newly developed COVID-19 antigen test product “BinaxNOW™ COVID-19 Ag Card (BinaxNOW or COVID-19 Silver Card)” (EUA). It is highly portable (about the size of a credit card) and relatively inexpensive, and can quickly and reliably detect active coronavirus infections.
It uses the proven Abbott lateral flow technology, which qualifies the nucleocapsid protein antigen in SARS-CoV-2, which comes from nasal swabs of patients suspected of COVID-19.